Background To summarize the antiviral activities of remdesivir against SARS-CoV-2, the
causative agent of COVID-19. Methods Available publications were systematically explored …

Introduction COVID-19 cases are on surge; however, there is no efficient treatment or
vaccine that can be used for its management. Numerous clinical trials are being reviewed for …

Background and objectives An effective treatment option is not yet available for SARS-CoV2,
which causes the COVID-19 pandemic and whose effects are felt more and more every day …

Introducción: La pandemia por SARS-Cov-2 ha tenido un impacto negativo en múltiples
aspectos de la vida humana, tanto en lo físico, psicológico, económico, social y cultural. Las …

After the outbreak of SARS and MERS, the world is now in the grip of another viral disease
named COVID-19 caused by a beta Coronavirus–SARS COV-2 which appears to be the …

As no specific pharmacological treatment has been validated for use in coronavirus disease
2019 (COVID-19), we aimed to assess the effectiveness of azithromycin (AZM) in these …

The current management of COVID-19 is mostly limited to general supportive care and
symptomatic treatment. Ivermectin is a broad-spectrum anti-parasitic drug used widely for …

Introduction: The coronavirus disease 2019 (COVID-19) pandemic continues to challenge
healthcare services worldwide. Healthcare workers (HCWs) are key to the continued effort to …

Background Drug repurposing otherwise known as drug repositioning or drug re-profiling is
a time-tested approach in drug discovery through which new medical uses are being …

Background: A definitive treatment of SARS CoV-2 is yet to arrive and the human death toll
rises exponentially globally. In this health emergency, it might be useful to look into the old …